| Literature DB >> 30534914 |
Jasmin Abad-Restrepo1, Alejandro Díaz-Díaz2, Natalia Osorio-Cadavid1.
Abstract
Use of Intrathecal colistin has increased in recent years and has become an alternative for the management of infections of the central nervous system caused by multidrug resistant (MDR) bacteria. Evidence of therapeutic success and safety profile is increasing, particularly in MDR Acinetobacter baumanii infections in adults. Conversely, evidence in children is limited. We present a case of an 11-year-old female with postsurgical meningitis caused by an extensively resistant Pseudomonas aeruginosa strain and treated with venous and intrathecal colistin. The evidence of its use in children with nosocomial meningitis by MDR Gram negative bacteria is reviewed.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30534914 DOI: 10.4067/s0716-10182018000300321
Source DB: PubMed Journal: Rev Chilena Infectol ISSN: 0716-1018 Impact factor: 0.520